Cartesian Therapeutics's total assets for Q2 2025 were $388.89M, a decrease of -4.95% from the previous quarter. RNAC total liabilities were $391.42M for the fiscal quarter, a -9.17% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.